Poseida Therapeutics (PSTX) Stock Price, News & Analysis
Company Description
Poseida Therapeutics (NASDAQ: PSTX) is classified in the biological product (except diagnostic) manufacturing industry within the Biological Products, (no Disgnostic Substances) sector and carries a market capitalization of $925.9M, ranking #3,048 among all listed U.S. companies by market cap.
PSTX has gained 199.7% over the past year. Shares last traded at $9.50.
This page collects what Stock Titan holds for PSTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Poseida Therapeutics (PSTX) stock last closed at $9.50. Over the past 12 months, the stock has gained 199.7%. At a market capitalization of $925.9M, PSTX is classified as a small-cap stock with approximately 97.5M shares outstanding.
PSTX Rankings
Latest News
Poseida Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, acquisition, conferences, earnings. View all PSTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PSTX Company Profile & Sector Positioning
Poseida Therapeutics (PSTX) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.